Table 3.
|
Baseline |
Clinical trial |
|
||||
---|---|---|---|---|---|---|---|
Number of patients | Patients treated with antibiotics | Antibiotic prescribing rate (%) | Number of patients | Patients treated with antibiotics | Antibiotic prescribing rate (%) | P | |
Control group |
|
|
|
|
|
|
|
GP A |
6 |
2 |
(33) |
12 |
8 |
(66) |
0.3 |
GP B |
4 |
2 |
(50) |
14 |
7 |
(50) |
1.0 |
GP C |
6 |
4 |
(66) |
8 |
8 |
(100) |
0.2 |
GP D |
5 |
5 |
(100) |
8 |
8 |
(100) |
1.0 |
GP E |
6 |
2 |
(33) |
10 |
6 |
(60) |
0.6 |
GP F |
7 |
6 |
(86) |
10 |
7 |
(70) |
0.6 |
Total |
34 |
21 |
(62) |
62 |
44 |
(71) |
0.4 |
Intervention group |
|
|
|
|
|
|
|
GP G |
7 |
2 |
(28) |
19 |
8 |
(42) |
0.7 |
GP H |
6 |
5 |
(83) |
10 |
4 |
(40) |
0.1 |
GP J |
5 |
5 |
(100) |
10 |
6 |
(60) |
0.2 |
GP K |
7 |
2 |
(28) |
12 |
1 |
(8) |
0.5 |
GP L |
9 |
3 |
(33) |
10 |
0 |
(0) |
0.1 |
GP M |
7 |
7 |
(100) |
10 |
4 |
(40) |
0.08 |
GP N |
6 |
4 |
(66) |
10 |
7 |
(70) |
1.0 |
Total | 47 | 28 | (59) | 81 | 30 | (37) | 0.02 |